Application 084840
- Type
- ANDA
- Sponsor
- LANNETT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ACETAZOLAMIDE | ACETAZOLAMIDE | TABLET;ORAL | 250MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A084840-001 | ACETAZOLAMIDE | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A084840-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A084840-001 | ACETAZOLAMIDE | 250MG | TABLET / ORAL | AB | Approved before 1982 | e64feba35796… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A084840-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A084840-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A084840-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A084840-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A084840-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A084840-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A084840-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A084840-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A084840-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A084840-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A084840-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A084840-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A084840-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A084840-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A084840-001 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A084840-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A084840-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A084840-001 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A084840-001 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A084840-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A084840-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A084840-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A084840-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A084840-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A084840-001 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A084840-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A084840-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A084840-001 | AB | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A084840-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A084840-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A084840-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A084840-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A084840-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A084840-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A084840-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A084840-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A084840-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A084840-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A084840-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A084840-001 | AB | 1 | e64feba35796… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetazolamide | ACETAZOLAMIDE SODIUM | Sagent Pharmaceuticals | 58093032-8480-4d0f-82be-92e643bdbea4 | 2026-01-09 | Warnings, Adverse reactions | Acetazolamide |
| Acetazolamide | ACETAZOLAMIDE | AvPAK | a9dca448-5511-413e-e053-2a95a90a8c66 | 2026-01-08 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE | PD-Rx Pharmaceuticals, Inc. | c525ef20-ec9a-4ffd-b5ea-e53c186fe716 | 2026-01-05 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| acetazolamide | ACETAZOLAMIDE | Northwind Health Company, LLC | f8232eaf-e108-aa00-e053-6394a90aede4 | 2026-01-01 | Warnings, Adverse reactions | acetazolamide ACETAZOLAMIDE |
| acetazolamide | ACETAZOLAMIDE | Accord Healthcare Inc. | 9a368b35-cd51-47ad-83cc-ccc56c4585e8 | 2025-12-15 | Warnings, Adverse reactions | acetazolamide ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE | Aarkish Pharmaceuticals NJ Inc. | ddfd44dc-3136-4dda-8ed0-eb2991c2a0b6 | 2025-12-08 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE | Eywa Pharma Inc | c19166fa-2cef-4c96-a956-ea540a8ba9c3 | 2025-12-05 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE | Ingenus Pharmaceuticals, LLC | a1f6ed35-9188-4115-8a3c-1ac91c07bf7d | 2025-12-05 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE | Ajanta Pharma USA Inc. | 240ab24b-3124-4805-80c2-36dd1945e3b3 | 2025-12-02 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE | Advagen Pharma Ltd | c24d31f0-a556-4e53-97a9-4e05e28ca40f | 2025-11-12 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| ACETAZOLAMIDE | ACETAZOLAMIDE | Aurobindo Pharma Limited | 513da48f-8f12-4696-b862-e8d882bf8611 | 2025-11-03 | Warnings, Adverse reactions | ACETAZOLAMIDE ACETAZOLAMIDE |
| AcetaZOLAMIDE | ACETAZOLAMIDE | Hikma Pharmaceuticals USA Inc. | 5502e5ba-9b5e-460a-855f-60534b625461 | 2025-11-03 | Warnings, Adverse reactions | AcetaZOLAMIDE ACETAZOLAMIDE |
| acetaZOLAMIDE | ACETAZOLAMIDE | Viona Pharmaceuticals Inc | 5473c171-dc2d-4a82-bbf1-0f5fad10f673 | 2025-11-03 | Warnings, Adverse reactions | acetaZOLAMIDE ACETAZOLAMIDE |
| acetaZOLAMIDE | ACETAZOLAMIDE | Zydus Lifesciences Limited | df84fea3-8947-403f-b470-1eeb6c4c293d | 2025-10-31 | Warnings, Adverse reactions | acetaZOLAMIDE ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 60f656ff-97b1-4a89-99af-8100483c2bac | 2025-06-25 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE | Gland Pharma Limited | 2b9fb0dd-e42e-4f9b-bf24-98b268d877e5 | 2025-06-18 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE | XGen Pharmaceuticals DJB, Inc. | a9199d3c-ce52-4db5-aa36-408f4e15e344 | 2025-06-02 | Warnings, Adverse reactions | Acetazolamide ACETAZOLAMIDE |
| acetazolamide | ACETAZOLAMIDE | American Health Packaging | 4e8797d9-2e78-49e0-af25-ac5d1f792499 | 2025-05-30 | Warnings, Adverse reactions | acetazolamide ACETAZOLAMIDE |
| Acetazolamide | ACETAZOLAMIDE SODIUM | Mylan Institutional LLC | 521838b0-a10d-495f-a014-f9ff25a6b6f3 | 2025-02-17 | Warnings, Adverse reactions | Acetazolamide |
| AcetaZOLAMIDE | ACETAZOLAMIDE | Hikma Pharmaceuticals USA Inc. | 85975cf0-1286-4af9-ac7f-94bb2483bf09 | 2025-02-04 | Warnings, Adverse reactions | AcetaZOLAMIDE ACETAZOLAMIDE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0527-1050 | AcetaZOLAMIDE | Acetazolamide | Lannett Company, Inc. | ANDA | Current |
| 0527-1050 | AcetaZOLAMIDE | Acetazolamide | Lannett Company, Inc. | ANDA | Current |
| 0527-1050 | AcetaZOLAMIDE | Acetazolamide | Lannett Company, Inc. | ANDA | Current |
| 0527-1050 | AcetaZOLAMIDE | Acetazolamide | Lannett Company, Inc. | ANDA | Current |
| 10135-567 | AcetaZOLAMIDE | Acetazolamide | Marlex Pharmaceuticals Inc | ANDA | Current |
| 10135-567 | AcetaZOLAMIDE | Acetazolamide | Marlex Pharmaceuticals Inc | ANDA | Current |
| 42291-103 | AcetaZOLAMIDE | Acetazolamide | AvKARE, Inc. | ANDA | Current |
| 42291-103 | AcetaZOLAMIDE | Acetazolamide | AvKARE, Inc. | ANDA | Current |
| 42291-103 | AcetaZOLAMIDE | Acetazolamide | AvKARE | ANDA | Current |
| 50090-3003 | AcetaZOLAMIDE | Acetazolamide | A-S Medication Solutions | ANDA | Current |
| 50090-3003 | AcetaZOLAMIDE | Acetazolamide | A-S Medication Solutions | ANDA | Current |
| 50090-3003 | AcetaZOLAMIDE | Acetazolamide | A-S Medication Solutions | ANDA | Current |
| 67296-0801 | AcetaZOLAMIDE | Acetazolamide | RedPharm Drug Inc. | ANDA | Current |
| 68084-541 | AcetaZOLAMIDE | Acetazolamide | American Health Packaging | ANDA | Current |
| 68084-541 | AcetaZOLAMIDE | Acetazolamide | American Health Packaging | ANDA | Current |
| 68084-541 | AcetaZOLAMIDE | Acetazolamide | American Health Packaging | ANDA | Current |